Transgene Announces Financial Calendar for 2021
17 Dicembre 2020 - 5:45PM
Business Wire
Regulatory News
Transgene (Paris:TNG) today announced its financial reporting
dates for 2021:
March 10, 2021:
2020 Fiscal Year Results
April 27, 2021:
First Quarter 2021 Financial Results
May 26, 2021:
Annual Shareholders' Meeting
September 22, 2021:
First Half 2021 Financial Results
November 4, 2021:
Third Quarter 2021 Financial Results
About Transgene Transgene (Euronext: TNG) is a
biotechnology company focused on designing and developing targeted
immunotherapies for the treatment of cancer. Transgene’s programs
utilize viral vector technology with the goal of indirectly or
directly killing cancer cells.
The Company’s clinical-stage programs consist of two therapeutic
vaccines (TG4001 for the treatment of HPV-positive cancers, and
TG4050, the first individualized therapeutic vaccine based on the
myvac® platform) as well as two oncolytic viruses (TG6002 for the
treatment of solid tumors, and BT-001, the first oncolytic virus
based on the Invir.IO™ platform).
With Transgene’s myvac® platform, therapeutic vaccination enters
the field of precision medicine with a novel immunotherapy that is
fully tailored to each individual. The myvac® approach allows the
generation of a virus-based immunotherapy that encodes
patient-specific mutations identified and selected by Artificial
Intelligence capabilities provided by its partner NEC.
With its proprietary platform Invir.IO™, Transgene is building
on its viral vector engineering expertise to design a new
generation of multifunctional oncolytic viruses. Transgene has an
ongoing Invir.IO™ collaboration with AstraZeneca. Additional
information about Transgene is available at: www.transgene.fr
Follow us on Twitter: @TransgeneSA
View source
version on businesswire.com: https://www.businesswire.com/news/home/20201217005732/en/
Transgene: Jean-Philippe Del/Lucie Larguier
+33 (0)3 88 27 91 04 investorrelations@transgene.fr
Media contacts: Citigate Dewe Rogerson David
Dible/Sylvie Berrebi +44 (0)20 7638 9571
transgene@citigatedewerogerson.com
Grafico Azioni Transgene (EU:TNG)
Storico
Da Mar 2024 a Apr 2024
Grafico Azioni Transgene (EU:TNG)
Storico
Da Apr 2023 a Apr 2024